{
    "eid": "2-s2.0-85163765891",
    "title": "Comparison of Antibody Persistence up to 6 Months after Additional Booster Vaccination with ChAdOx1 nCoV-19 Vaccine",
    "cover-date": "2023-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Microbiology",
            "@code": "2404",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Molecular Biology",
            "@code": "1312",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Microbiology (medical)",
            "@code": "2726",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "booster",
        "ChAdOx1 nCoV-19",
        "COVID-19",
        "durability",
        "immunogenicity",
        "neutralizing antibodies",
        "SARS-CoV-2"
    ],
    "authors": [
        "Pawita Suwanwattana",
        "May Han",
        "Tanawin Nopsopon",
        "Phanupong Phutrakool",
        "Chatpol Samuthpongtorn",
        "Wannarat Pongpirul",
        "Wisit Prasithsirikul",
        "Krit Pongpirul"
    ],
    "citedby-count": 0,
    "ref-count": 17,
    "ref-list": [
        "Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: A narrative review",
        "An Asia-Pacific study on healthcare workers\u2019 perceptions of, and willingness to receive, the COVID-19 vaccination",
        "COVID-19 seroprevalence among hospital staff and preprocedural patients in Thai community hospitals: A cross-sectional study",
        "Seroprevalence of hospital staff in a province with zero COVID-19 cases",
        "Safety and immunogenicity of inactivated COVID-19 vaccine in health care workers",
        "SARS-CoV-2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two-dose CoronaVac vaccine regimen",
        "Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): A blinded, multicentre, randomised, controlled, phase 2 trial",
        "Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: A substudy of two randomised controlled trials (COV001 and COV002)",
        "Immunogenicity of ChAdOx1 nCoV-19 Booster Vaccination Following Two CoronaVac Shots in Healthcare Workers",
        "The WHO International Standard for COVID-19 serological tests: Towards harmonization of anti-spike assays",
        "Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: A data linkage study",
        "Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021\u2013January 2022: A retrospective, population-based, matched cohort study",
        "Immunogenicity and safety of homologous and heterologous booster vaccination of ChAdOx1 nCoV-19 (COVISHIELD\u2122) and BBV152 (COVAXIN\u00ae): A non-inferiority phase 4, participant and observer-blinded, randomised study",
        "Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England",
        "Effectiveness of Booster Vaccinations on the Control of COVID-19 during the Spread of Omicron Variant in Malaysia"
    ],
    "affiliation": [
        {
            "affiliation-city": "Liverpool",
            "@id": "60020661",
            "affilname": "University of Liverpool",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020661",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Nontaburi",
            "@id": "60015728",
            "affilname": "Thailand Ministry of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015728",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Baltimore",
            "@id": "60006183",
            "affilname": "Johns Hopkins Bloomberg School of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006183",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60002746",
            "affilname": "Harvard Medical School",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002746",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "National Research Council of Thailand"
    ]
}